Center for Medicare Advocacy

Advancing Access to Medicare and Healthcare

Medicare Part D / Prescription Drugs

Center for Medicare Advocacy Sues, Again, for Coverage of “Off-label” Prescription Drug

On November 18, 2022, the Center for Medicare Advocacy and Murphy Orlando LLC filed suit on behalf of a retired public-school teacher in New Jersey who seeks coverage of her “off-label” (non-FDA-approved) use of a critically needed medication. … [Read more...] about Center for Medicare Advocacy Sues, Again, for Coverage of “Off-label” Prescription Drug

President Biden Signs Inflation Reduction Act into Law – Includes Critical Medicare Prescription Drug Provisions

On Tuesday, August 16, 2022, President Biden signed into law the Inflation Reduction Act (IRA) of 2022, which includes expansive health and climate provisions.  This bill is the culmination of over a year of debate about a wide range of … [Read more...] about President Biden Signs Inflation Reduction Act into Law – Includes Critical Medicare Prescription Drug Provisions

Senate Poised to Vote on Important Bill with Valuable Medicare Drug Provisions

The Senate is nearing a vote on the Inflation Reduction Act (IRA) of 2022, a scaled back, but still transformational, reconciliation package that includes critical Medicare prescription drug and Affordable Care Act (ACA) improvements.Among other … [Read more...] about Senate Poised to Vote on Important Bill with Valuable Medicare Drug Provisions

CMS Needs to Rein in Medicare Advantage Overpayments and Heighten Oversight of Insurance Industry

Center Comments Regarding CMS’ Advance Payment Notice and Proposed Part C & D RuleThe Center for Medicare Advocacy recently submitted comments to the Centers for Medicare & Medicaid Services (CMS) regarding their Advance payment rule … [Read more...] about CMS Needs to Rein in Medicare Advantage Overpayments and Heighten Oversight of Insurance Industry

CMS Releases Proposed 2023 Rule for Medicare Advantage and Part D Plans

On January 6, 2022, CMS released CY 2023 Medicare Advantage and Part D Proposed Rule (CMS-4192-P) and an accompanying Press Release describing the overall rule, and a separate Press Release focusing on Part D prescription drug costs.  The … [Read more...] about CMS Releases Proposed 2023 Rule for Medicare Advantage and Part D Plans

Study Finds Cost-Sharing Increases Can be Deadly

A recent study supports the Center for Medicare Advocacy’s long-held concern about increasing out-of-pocket costs for Medicare beneficiaries. In summary, requiring beneficiaries to pay more of their own money will not make them savvier consumers; … [Read more...] about Study Finds Cost-Sharing Increases Can be Deadly

Final 2022 Rule for Medicare Parts C and D Released By Trump Administration

I. OverviewOn February 18, 2020, the Centers for Medicare & Medicaid Services (CMS) issued a proposed rule entitled “Medicare and Medicaid Programs; Contract Year 2021 and 2022 Policy and Technical Changes to the Medicare Advantage Program, … [Read more...] about Final 2022 Rule for Medicare Parts C and D Released By Trump Administration

Dismantling the Affordable Care Act Would Harm Medicare and Medicare Beneficiaries

Spotlight on Closing the Part D Coverage Gap (“Donut Hole”)The Supreme Court will review the constitutionality of the Affordable Care Act (ACA) this term in California v. Texas, with oral argument scheduled for November 10, 2020. This … [Read more...] about Dismantling the Affordable Care Act Would Harm Medicare and Medicare Beneficiaries

Senators Release Report Concerning Postal Service Problems and Delays in Receipt of Mail-Order Drugs

On September 9, 2020, U.S. Senators Bob Casey and Elizabeth Warren released a report entitled “Rapidly Increasing Postal Service Delivery Delays for Mail-Order.” The report focuses on recent operational changes made at the U.S. Postal Service (USPS) … [Read more...] about Senators Release Report Concerning Postal Service Problems and Delays in Receipt of Mail-Order Drugs

Skip to content